MYR 0.61
(0.83%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 12.89 Million MYR | -12.25% |
2022 | 14.69 Million MYR | 19.46% |
2021 | 12.29 Million MYR | 118.01% |
2020 | 5.64 Million MYR | -27.97% |
2019 | 7.83 Million MYR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 3.01 Million MYR | -5.13% |
2024 Q2 | 3.76 Million MYR | 25.05% |
2023 Q3 | 2.84 Million MYR | -25.71% |
2023 FY | 12.89 Million MYR | -12.25% |
2023 Q2 | 3.82 Million MYR | 25.3% |
2023 Q1 | 3.05 Million MYR | -20.46% |
2023 Q4 | 3.17 Million MYR | 11.87% |
2022 Q3 | 3.68 Million MYR | 0.0% |
2022 FY | 14.69 Million MYR | 19.46% |
2022 Q4 | 3.83 Million MYR | 4.15% |
2021 FY | 12.29 Million MYR | 118.01% |
2020 FY | 5.64 Million MYR | -27.97% |
2019 FY | 7.83 Million MYR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Artroniq Berhad | -5.51 Million MYR | 333.744% |
QES Group Berhad | 18.46 Million MYR | 30.198% |
Pharmaniaga Berhad | -80.16 Million MYR | 116.082% |
Apex Healthcare Berhad | 397.98 Million MYR | 96.761% |